Bausch Health Companies Inc BHC

NYS: BHC | ISIN: CA0717341071 24/03/2026

4,990 USD (-2,16%)

(-2,16%) 24/03/2026

Grafiek Bausch Health Companies Inc

Grafiek Bausch Health Companies Inc

1 dag1d -2,16%
1 week1w -1,96%
1 maand1m -18,33%
3 maanden3m -30,69%
6 maanden6m -22,76%
1 jaar1j -28,71%
5 jaar5j -83,95%

Bausch Health Companies Inc in het nieuws

Toon enkel gratis nieuws

23 februari 2026 · Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada · Persbericht

19 februari 2026 · Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres · Persbericht

18 februari 2026 · Bausch Health Announces Fourth Quarter And Full-Year 2025 Results · Persbericht

17 februari 2026 · Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference · Persbericht

11 februari 2026 · Bausch Health Announces 2026 Gastrointestinal Health Scholars Program · Persbericht

23 januari 2026 · Bausch Health Provides Update on RED-C Phase 3 Clinical Trials · Persbericht

21 januari 2026 · Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026 · Persbericht

5 januari 2026 · Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference · Persbericht

11 september 2025 · Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio · Persbericht

29 juli 2025 · Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease · Persbericht

Profiel Bausch Health Companies Inc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

Website: www.bauschhealth.com

Hoofdzetel: Laval Canada

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe